You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inhibitor of nuclear export

Showing 1 - 25 of 8,379
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

Active, not recruiting
  • Recurrent Melanoma
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022

Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI

Recruiting
  • Advanced Alveolar Soft Part Sarcoma
  • +3 more
  • Atezolizumab
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jan 28, 2023

MDS Trial in New York (selinexor (KPT-330))

Completed
Has Results
  • Myelodysplastic Syndromes
  • selinexor (KPT-330)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 11, 2022

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 5, 2022

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt

Active, not recruiting
  • Prolymphocytic Leukemia
  • +4 more
  • Columbus, Ohio
  • +1 more
Apr 29, 2022

Refractory Multiple Myeloma Trial in United States (selinexor, carfilzomib, dexamethasone)

Recruiting
  • Refractory Multiple Myeloma
  • Scottsdale, Arizona
  • +4 more
Apr 1, 2022

Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

Recruiting
  • Advanced Urothelial Carcinoma
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jun 28, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in

Suspended
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +4 more
  • Detroit, Michigan
  • +1 more
Feb 2, 2022

1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer Trial in Chongqing (ATG-008,

Not yet recruiting
  • 1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer
  • Chongqing, Chongqing, China
    Chongqing Cancer Hospital
Aug 4, 2021

Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Duarte, California
  • +4 more
Jan 30, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Des Moines, Iowa
  • +8 more
Jan 12, 2023

Ovarian Cancer, Endometrial Cancer Trial in Middletown, Harrison, New York (Paclitaxel, Carboplatin, Selinexor)

Completed
  • Ovarian Cancer
  • Endometrial Cancer
  • Middletown, New Jersey
  • +2 more
Apr 22, 2021

Solid Tumors Trial in United States (SL-801)

Terminated
  • Solid Tumors
  • New Haven, Connecticut
  • +5 more
Jan 27, 2022

Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 12, 2021

Hematological Malignancies Trial in Canada, Denmark, United States (KPT-330)

Completed
Has Results
  • Hematological Malignancies
  • Tampa, Florida
  • +11 more
Mar 5, 2021

Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Frankfurt am Main, Hannover, Hamburg (Selinexor, Idarubicin, Cytarabine)

Completed
Has Results
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Frankfurt am Main, Hessen, Germany
  • +2 more
Aug 1, 2021

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
Apr 27, 2021

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Ovarian Carcinoma, Endometrial Carcinoma, Cervical Carcinoma Trial in Belgium, Denmark (Selinexor)

Completed
Has Results
  • Ovarian Carcinoma
  • +2 more
  • Leuven, Belgium
  • +3 more
Jan 13, 2021

Solid Tumor Trial in Canada, Denmark, United States (Selinexor, Acetaminophen)

Completed
Has Results
  • Solid Tumor
  • Tampa, Florida
  • +5 more
Apr 6, 2021

Solid Tumors Trial in Singapore (KPT-330)

Completed
  • Solid Tumors
  • Singapore, Singapore
    National University Hospital
Sep 8, 2020